P

Pillar Clinical Research | Bentonville, AR

Research site

(Unclaimed)

Location

3200 North East Red Hawk Drive, Bentonville, Arkansas, United States of America

Site insights

Top conditions

Top treatments

Cariprazine

KarXT

BHV-7000

IXT-m200

MK-8189

JZP385

NMRA-335140

BIIB104

MK-8189-008

LB-102

Parent organization

This site is a part of Pillar Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 19 total trials

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder. (3112 Ped BPD)

Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United S...

Enrolling

Bipolar I Disorder

Depression

Drug: Placebo

Drug: Cariprazine

Status recently updated

BHV-7000 Acute Treatment of Bipolar Mania

The purpose of this study is to determine whether BHV-7000 is a safe and effective acute treatment for manic episodes in bipolar disorder I.

Enrolling

Active, not recruiting

Bipolar Disorder

Drug: Placebo

Drug: BHV-7000

BHV-7000 Open-Label Extension Bipolar Mania Study

The purpose of this study is to evaluate the long-term safety and tolerability of BHV-7000 in subjects with bipolar I disorder.

Invitation-only

Bipolar Disorder

Drug: BHV-7000

Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder

The purpose of this study is to evaluate the long-term safety and tolerability of cariprazine in the treatment of pediatric participants with schizop...

Active, not recruiting

Bipolar I Disorder

Schizophrenia

Drug: Cariprazine Flexible Dose

Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia

This is a Phase 2, randomized, double-blind, placebo-controlled, multi-center inpatient study to evaluate the efficacy and safety of LB-102 in adult...

Active, not recruiting

Schizophrenia

Drug: LB-102